Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adult acellular pertussis booster memory response study
2013-005355-32Phase 4Completed
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Feb 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acellular pertussis vaccine in pertussis, sponsored by National Institute for Public Health and the Environment. Primary endpoints: Longitudinal humoral and cellular memory immunity against Bordetella pertussis and Antibody kinetics in serum and saliva. Started Feb 2014; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on 2013-005355-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005355-32.